Transcriptional regulation is mainly focused on the initiation process, which entails recruitment of RNAPII and the general transcriptional factors to a promoter. Mediator, a multisubunit complex conserved throughout all eukaryotes, interacts with RNAPII and functions as a key regulator of RNAPII-dependent gene expression by integrating and conveying regulatory signals from activators and repressors to the basal transcription machinery 1-4 . The structure, subunit organization and RNAPII interaction of Mediator are the subject of intense investigation because understanding them is essential for discerning the mechanism underlying transcription regulation. Mediator comprises four core structural modules 5 (head, middle, tail and arm) plus a dissociable CKM, whose component subunits were individually recognized as transcriptional repressors 6 and genetically linked to the RNAPII CTD 7, 8 . Recent studies suggest a more nuanced role for the CKM in both repression and activation 9 , and mutations of CKM subunits have been associated with development of several malignancies 9-11 .
a r t i c l e s
Transcriptional regulation is mainly focused on the initiation process, which entails recruitment of RNAPII and the general transcriptional factors to a promoter. Mediator, a multisubunit complex conserved throughout all eukaryotes, interacts with RNAPII and functions as a key regulator of RNAPII-dependent gene expression by integrating and conveying regulatory signals from activators and repressors to the basal transcription machinery [1] [2] [3] [4] . The structure, subunit organization and RNAPII interaction of Mediator are the subject of intense investigation because understanding them is essential for discerning the mechanism underlying transcription regulation. Mediator comprises four core structural modules 5 (head, middle, tail and arm) plus a dissociable CKM, whose component subunits were individually recognized as transcriptional repressors 6 and genetically linked to the RNAPII CTD 7, 8 . Recent studies suggest a more nuanced role for the CKM in both repression and activation 9 , and mutations of CKM subunits have been associated with development of several malignancies [9] [10] [11] .
In the yeast S. cerevisiae, the CKM is an ~430 kDa protein complex that can reversibly associate with Mediator and includes four subunits 12, 13 : Cdk8 (Srb10), CycC (Srb11), Med12 (Srb8) and Med13 (Srb9). CKM subunits were first identified through a genetic screen for mutations that would compensate for truncation of the CTD of Rpb1, the largest RNAPII subunit 7, 8 , which is essential for the interaction of RNAPII with Mediator and a number of other complexes important in RNAPII transcription regulation. In in vitro-reconstituted transcription assays, Mediator lacking the CKM has a stimulatory effect on basal transcription 14, 15 . In contrast, Mediator containing the CKM represses basal transcription 16, 17 , and genetic analysis has indicated that the CKM is also involved in negative gene regulation in vivo 17 . It was initially suggested that the CKM would suppress transcription by phosphorylating the RNAPII CTD, but it was later discovered that CKM transcription repression is independent of its Cdk8 kinase activity 18, 19 . However, it was reported that binding of the human CKM to Mediator interferes with RNAPII recruitment and represses transcription reinitiation 18 .
Repression by the CKM in the absence of kinase activity could be related to the observation that the CKM has a direct effect on the interaction of RNAPII with Mediator. Formation of a Mediator-RNAPII holoenzyme is largely blocked by association of the CKM with Mediator 19, 20 . In Schizosaccharomyces pombe, it was proposed that the CKM prevents RNAPII interaction with Mediator by directly blocking the RNAPII-binding site 19 . In contrast, studies in the human system led to the suggestion that the CKM inhibits polymerase interaction through an effect on Mediator conformation 18 . However, neither of these hypotheses explains why CKM subunits were identified in a genetic screen for CTD truncations.
We used a combination of macromolecular EM and biochemistry to study the interaction between Mediator and the CKM and to investigate the mechanism behind the effect of the CKM on transcription initiation. We determined the structure and subunit organization of the S. cerevisiae CKM and characterized its interaction with core Mediator. We found that the structure, subunit organization and mode of Mediator-CKM interaction are conserved between yeast and humans. In yeast, the strongest Mediator-CKM interaction involved a discrete contact through subunit Med13, and biochemical and EM data indicated additional weaker interactions between the CKM and 6 1 2 VOLUME 20 NUMBER 5 MAY 2013 nature structural & molecular biology a r t i c l e s the middle module. We discovered that Mediator-CKM interaction interferes with CTD-dependent RNAPII binding to a previously unknown site on the middle Mediator module and with holoenzyme formation. In combination with biochemical results, our EM observations suggest that obstruction of CTD-dependent RNAPII interaction with the middle module explains the repressive effect of the CKM on transcription and the observed genetic interaction between CKM subunit mutations and truncation of the RNAPII CTD.
RESULTS
Yeast CKM purification and electron microscopy structure We purified native CKM from yeast by using a tandem affinity purification (TAP) protocol 21 . SDS-PAGE analysis showed that tagging of the CKM subunit Cdk8 resulted in purification of a complete, kinaseactive CKM (Supplementary Note and Supplementary Fig. 1 ).
To investigate the CKM structure, we imaged purified CKM particles in the electron microscope after preserving them in stain. EM images showed elongated particles that were well preserved and homogeneous in size and overall appearance (Fig. 1a) . Twodimensional (2D) class averages obtained after alignment and averaging of the images showed that the CKM is roughly 200 × 100 Å in size, with two bent features protruding from a globular central density (Fig. 1a, inset) . The purity and conformational homogeneity of the purified CKM fractions allowed us to use the random conical tilt technique 22 to determine an initial three-dimensional (3D) structure of the CKM (Fig. 1b) by using images of tilted and untilted CKM specimens. A more faithful view of the CKM structure came from a cryo-EM map of the complex at ~15-Å resolution, calculated from ~70,000 CKM cryo-images (Fig. 1c, Supplementary Note and  Supplementary Fig. 2 ).
Yeast CKM subunit organization
To understand the molecular organization of the yeast CKM, we set out to determine the position of individual subunits within the complex. The locations of all four CKM component subunits were mapped through a combination of subunit deletion-mutant imaging and antibody labeling. A calmodulin-binding peptide (CBP) left at the C terminus of either Cdk8 or CycC after CKM purification from TAP-tagged strains could be localized by mixing the tagged, purified CKM with anti-CBP antibodies, followed by EM imaging after npg a r t i c l e s particle preservation in stain. After anti-CBP antibody labeling, 2D class averages calculated from Cdk8-TAP particles clearly showed antibody-like density around the distal portion of the bottom end of the CKM structure (Fig. 1d) , thus indicating the location of the Cdk8 subunit. Anti-CBP labeling of CycC showed that this subunit is adjacent to Cdk8, consistent with expected component interaction in this kinase-cyclin pair (Fig. 1e) . To further confirm the position of Cdk8 within the CKM complex, we purified CKM from a ∆Cdk8 deletion strain and analyzed it by EM. Comparing a 2D class average calculated from wild-type CKM particles ( Fig. 1f) with one obtained from ∆Cdk8 CKM particles highlights the absence of a small piece of density at the same distal lower end of the CKM structure targeted by anti-CBP antibodies in the Cdk8-TAP particles (Fig. 1f) .
We were unable to TAP tag the Med13 C terminus for antibody labeling, but we could localize Med13 through EM analysis of a ∆Med13 deletion strain generated in a CycC-TAP background (as with CycC, Med13 is nonessential, and Med13 deletion results only in a phenotype of flocculation under standard culture conditions). A 2D class average from ∆Med13 CKM particles showed a structure much smaller than the wild-type complex. A difference map between the wild-type and ∆Med13 CKM 2D averages indicated that Med13 forms the top end of the CKM structure (Fig. 1f) . Taken together with the results from Cdk8 and CycC localization, this implies that Med13 and the Cdk8-CycC kinase-cyclin pair are at opposite ends of the CKM structure, connected by a central Med12 (Fig. 1g) . Finally, the crystal structure of the human Cdk8-CycC complex 23 (PDB 3RGF) could be unambiguously fitted in a unique position and orientation into our cryo-EM reconstruction of the CKM complex, thus confirming our localization results for the Cdk8-CycC kinase-cyclin pair (Fig. 1h) and indicating that Cdk8 does not interact directly with either Med12 or Med13 but instead interfaces with Med12 through CycC.
Interaction of the CKM with Mediator
The human CKM has been reported to interact with Mediator through a contact involving CKM subunit MED13 and a 'hook' at one end of the human Mediator structure 18 . We were interested in studying the Mediator-CKM interaction in yeast to shed light on the mechanism by which CKM impinges on Mediator regulation and to investigate the origin of the genetic connection between the CKM and the CTD. We started by mixing purified yeast Mediator and CKM. Incubation of Mediator with CKM immobilized on a calmodulin resin through a CBP tag on the CycC C terminus resulted in formation of a stable Mediator-CKM complex (Fig. 2a) . Comparison of averages obtained from images of Mediator-CKM complex particles to a 2D EM map of Mediator alone (Fig. 2b) indicated that, under the conditions of our binding experiment, Mediator and the CKM interacted in a number of ways. We observed a well-defined contact between one end of the CKM structure and the hook at the very end of the Mediator structure (Fig. 2c , ~30% of particles), as reported for the human CKM 18 . We also observed an additional, less-frequent contact between the opposite end of the CKM structure and a point on the back side of the middle Mediator module (Fig. 2c , ~10% of particles). In about 60% of particles, the CKM had an extended interface with Mediator (Fig. 2c) . In fact, careful clustering of Mediator-CKM particle images revealed a Discrete, localized contacts between either end of the CKM and Mediator must involve subunits Med13 and Cdk8, which form the tips of the CKM structure. To unequivocally identify the CKM subunit interacting with the terminal Mediator hook, we repeated the Mediator-CKM interaction experiment, this time using ∆Cdk8 CKM, and analyzed the resulting assemblies by EM. The resulting 2D class average (Fig. 2d) showed ∆Cdk8 CKM bound to the hook, which indicates that Med13 (at the end of the CKM structure opposite to Cdk8) is the subunit involved in interaction with the hook. Consequently, the CKM must contact the Mediator middle module through subunit Cdk8. These conclusions are in agreement with a previous report of interaction of human Med13 with the hook at the end of the human Mediator structure 18 and with reported interaction of the Cdk8-CycC kinase-cyclin pair with subunits Med1 and Med4 in the yeast middle Mediator module 24 .
Two observations suggested that the contact between Med13 and the Mediator hook is the dominant interaction. First, EM analysis after incubation of ∆Med13 CKM with Mediator revealed only minimal complex formation, but EM analysis after incubation of ∆Cdk8 CKM with Mediator showed formation of a complex in which the Med13 contact was established but the position of the ∆Cdk8 CKM was highly variable (Fig. 2d) . Second, in binding assays in which immobilized ∆Med13 or ∆Cdk8 CKM were incubated with Mediator, deletion of Med13 eliminated interaction of CKM with Mediator, whereas deletion of Cdk8 only weakened it (Fig. 2e) . Wild-type CKM exhibited the strongest binding, probably owing to a large Mediator-CKM interface, and the Med13-tail contact appeared to be stronger than the Cdk8-middle contact. We were also able to determine maps that provided a 3D view of the predominant modes of yeast Mediator-CKM interaction (Fig. 2f,g and Supplementary Note).
The yeast CKM interacts with the middle Mediator module
Interaction of the CKM with the top portion of the Mediator structure indicated that the middle and tail Mediator modules (module subunit composition is listed in Supplementary Fig. 3a ) could be involved in interaction with the CKM. We were able to purify a yeast Mediator subcomplex including all middle-module subunits from a ∆Med16 yeast Mediator strain (Supplementary Fig. 3b) . Comparison of 2D EM maps of Mediator and the middle module indicated that middlemodule subunits account for most, if not all, of the Mediator density contacted by the CKM, including the hook at the end of the Mediator contacted by Med13 (Fig. 2h) . Thus, although we cannot exclude the possibility of some contact between the CKM and tail-module subunits, we conclude that the yeast CKM interacts primarily with middle-module subunits. This was confirmed by EM analysis following incubation of purified CKM and middle module (data not shown).
Conserved CKM organization and Mediator interaction
To directly compare the Mediator-CKM interaction in yeast and humans, we carried out EM and biochemical studies of the human Mediator-CKM interaction. First, we analyzed EM images of human Mediator-CKM particles 25 . A 2D map of free human Mediator showed a clear overall resemblance to a corresponding yeast Mediator map (Fig. 3a) . In particular, the hook at the end of the human Mediator's tail module appears markedly similar to the corresponding portion of the yeast Mediator structure. We found that, as reported 18 , the human CKM bound to the human Mediator's hook ( Fig. 3a and  Supplementary Fig. 3c,d) . The overall structure of the human CKM appeared very similar to that of its yeast counterpart, which could be better appreciated when the human CKM was independently aligned to reduce blurring due to variability in its position with respect to human Mediator (Fig. 3a) .
Next we turned to biochemical analysis to identify human CKM subunits involved in interaction with the human Mediator. We used short interfering RNA (siRNA) to deplete specific CKM subunits in a HeLa cell line in which the MED19 subunit had been Flag tagged. Flag-MED19-associated proteins were then immunopurified on anti-Flag M2 agarose and analyzed by immunoblotting. MED12 and MED13 (and the metazoan-specific MED13-like subunit) remained associated with Mediator purified through the Flag-MED19 tag after depletion of CDK8 or CycC (Fig. 3b) . The entire CKM was displaced when both MED13 and MED13-like were depleted, but depletion of MED12 led to loss of Cdk8 and CycC without affecting association of MED13 or MED13-like with Mediator (Fig. 3b) . These results coincide with our observations in the yeast system. Also, the human CKM-subunit depletion results imply that the subunit organization of the human CKM mirrors that of the yeast CKM, with MED13 and Cdk8-CycC organized around a centrally positioned MED12.
We then investigated which human Mediator subunits were involved in interaction with human CKM subunits MED13 and MED12. Flagtagged MED12 or MED13 was transiently transfected into HEK293T cells with individual myc-tagged Mediator subunits. Tagged human CKM subunits were immunopurified on anti-Flag M2 agarose resin, and copurified myc-tagged Mediator subunits were analyzed by immunoblotting. MED13 interacted with human middle-module subunits MED1, MED26, MED19 and MED7 (Fig. 3c) . MED12 also interacted with MED1 and MED26, but in addition it interacted with MED14, also a human middle-module subunit (Fig. 3c) . Detection of a small amount of MED13 in cells not expressing Flag-MED13 was due to the presence of a small amount of endogenous MED13. In addition, we could not determine whether small amounts of MED7 and MED19 copurified with MED12 because they interacted with it weakly or whether this was because of the presence of a small amount of endogenous MED13. We were not able to detect interactions between the CKM and individual human tail-module subunits (Fig. 3d) . Therefore, human Mediator middle-module subunits are primarily responsible for interactions with MED13 (strong) and MED12 (weak) (Fig. 3e) .
In conclusion, the Mediator-CKM interaction is largely conserved between yeast and humans and depends primarily on a strong contact between CKM subunit MED13 and middle-module subunits, with other CKM subunits (MED12 in humans; Cdk8 and CycC in yeast) establishing weaker interactions. To understand how these Mediator-CKM interactions might affect transcription regulation, we analyzed how the CKM affects the interaction of RNAPII and its CTD with Mediator.
CTD binding to the head and middle Mediator modules
We examined the yeast Mediator-CTD interaction by analyzing EM images recorded after incubation of Mediator and a full-length unphosphorylated CTD with a glutathione S-transferase (GST) tag at the N terminus (which could be directly visualized in EM images) or a full-length unphosphorylated CTD with a hexahistidine (His 6 ) tag at the C terminus (which could be localized through secondary labeling with an anti-His 6 antibody). Consistent with previous reports of CTD binding to the yeast [26] [27] [28] and human 29 ( Supplementary  Fig. 4a ) head modules, EM images showed CTD density adjacent to the head Mediator module (Fig. 4a) . However, this accounted for only a small fraction (13% of particles) of observed CTD binding to npg a r t i c l e s Mediator, and most CTD density (87% of particles) was observed at a previously unknown site in the middle module (Fig. 4b) . Close correspondence between the positions of the N-terminal GST tag and antibody density directed toward the C-terminal His 6 tag on the CTD suggested that the unphosphorylated CTD adopts a compact conformation. Incubation of RNAPII purified through TAP tagging of the CTD (which leaves a CBP tag at the C-terminal end of the CTD) with anti-CBP antibodies indicated that the unphosphorylated CTD also adopts a compact conformation when attached to RNAPII (Supplementary Fig. 4b,c) .
To confirm independent binding of the CTD to two different sites on Mediator, we incubated GST-CTD with purified middle or recombinant head modules and imaged the resulting complexes by EM. The resulting 2D class averages confirmed that the GST-CTD could bind both the head and middle modules (Fig. 4c,d) . The position of GST-CTD on the head module was consistent with the position for CTD binding in the X-ray model of the head-CTD complex 27 .
On the basis of these results, we conclude that the CTD binds strongly to a previously unknown site on the middle module and more weakly to a CTD-binding site on the head module.
RNAPII shows a variety of modes of Mediator binding
To understand the connection between the CTD and RNAPII binding to Mediator, we analyzed EM images recorded after incubation of purified Mediator and RNAPII. As expected 30 , no RNAPII binding was observed if CTD-less RNAPII was incubated with Mediator. Incubation of wild-type RNAPII (alone or in combination with TFIIF) with Mediator resulted in a majority (~90%) of Mediator-RNAPII particles showing RNAPII binding at or near the CTD-binding site on the middle module ( Fig. 4e and Supplementary Video 2) and only a minority of particles showing RNAPII binding at its reported position near the head module in the Mediator-RNAPII holoenzyme 31 ( Supplementary Fig. 5a ). This observation is consistent with predominant CTD binding to the middle module. 
npg a r t i c l e s
To examine the possibility that binding of RNAPII to the middle module might occur only when purified Mediator and RNAPII are incubated in vitro, we examined EM images of preformed Mediator-RNAPII holoenzyme particles purified directly from yeast by following the transcriptional activity of different fractions 31 . Analysis of these endogenous holoenzyme EM images with a stable clustering algorithm 32 revealed that RNAPII binds predominantly at two different places on Mediator. In about half the particles, RNAPII is found near the head module, interacting in a variety of ways (Fig. 4f) . In the rest of the particles, RNAPII is located near the CTD-binding site on the middle Mediator module, as observed after incubation of Mediator with RNAPII in vitro (Fig. 4f) . RNAPII binding near the head module is consistent with published structures of the yeast 31 and human 20 holoenzymes and with our recently published structure of a head-minimal preinitiation-complex assembly 33 . Variability in the precise mode of interaction between RNAPII and the head could probably explain presumed differences in the precise orientation of RNAPII in the yeast and human holoenzymes.
Two observations suggest that holoenzyme formation might be a multistep process initiated by CTD-dependent binding of RNAPII to the middle module. First, analysis of the endogenous holoenzyme images also shows RNAPII bound to Mediator at positions spanning the distance between the middle-and head-module sites (Fig. 4f) . Second, although RNAPII binds primarily to the middle module after in vitro incubation of purified Mediator with RNAPII, the fraction of particles with RNAPII bound closer to the head increases nearly five-fold (from ~5% to >20%) if Mediator and RNAPII are incubated in the presence of a recombinant Gcn4 activator.
The CKM interferes with RNAPII binding to the middle module
Overlap between the CKM and middle-module CTD-binding sites in yeast prompted us to investigate a possible effect of the CKM on Mediator-RNAPII interaction by incubating immobilized Med18 Flag-tagged Mediator with RNAPII and wild-type, ∆Med13 or ∆Cdk8 CKM. We found that RNAPII binding to Mediator decreased as the amount of wild-type CKM increased (Fig. 5a, lanes 4-6) . In contrast, ∆Med13 or ∆Cdk8 CKMs, in which the Mediator-CKM interaction is compromised, were unable to diminish binding of RNAPII to Mediator (Fig. 5a, lanes 7-9 and 10-12, respectively) .
Biochemical studies first highlighted the importance of the CTD for polymerase interaction with Mediator 34 , and EM observations showed that CTD-less RNAPII is unable to bind Mediator 30 . Therefore, next we asked whether the effect of CKM on RNAPII binding to Mediator might directly involve the CTD. First, we performed binding assays to show interaction of the CTD with Mediator under our experimental conditions (Supplementary Fig. 5b) . Next, we immobilized GST-CTD on beads and tested the effect of the CKM on interaction of the immobilized CTD with Mediator. We found that, as observed for RNAPII, binding of Mediator to the GST-CTD was diminished in the presence of wild-type CKM but not in the presence of ∆Med13 or ∆Cdk8 CKM (Fig. 5b) .
We also recorded EM images of yeast Mediator after incubation with both RNAPII and the CKM (Supplementary Fig. 6a-f) . As expected, considering the binding-assay results, the CKM bound to Mediator but RNAPII did not. This is explained by a large overlap between the binding positions for the CKM and RNAPII (Fig. 5c,  Supplementary Videos 1, 2 and Supplementary Fig. 6g) . These results indicate that the effect of the CKM on the interaction between Mediator and RNAPII could be explained by CKM inhibition of CTD binding to the middle Mediator module, which in turn could explain the identification of CKM subunits in a genetic screen for mutations that compensate for CTD truncation 7, 8 .
Structure and Mediator interaction of CKM SRB mutants
We studied two SRB mutations, Srb8-1 and Srb10-1, involving CKM subunits Med12 and Cdk8, respectively, which compensate for npg a r t i c l e s CTD truncation 8 . The sequences of the Srb8-1 and Srb10-1 mutants had not been reported, and we found that both mutations result in an introduction of stop codons that prevent translation of the full med12 and cdk8 gene products. In the case of the cdk8 Srb10-1 mutant, the sequence encoding residue Asn473 is changed to a stop codon that prevents translation of the 83 C-terminal residues (corresponding to 15% of the protein length) of Cdk8. We purified CKM lacking the 83 C-terminal amino acids of Cdk8 by introducing the Srb10-1 mutation in a yeast strain in which CycC was TAP tagged. SDS-PAGE analysis (Fig. 5d) showed that deletion of the 83 Cdk8 C-terminal residues does not affect CKM integrity, and a 2D average of the Srb10-1 CKM mutant (Fig. 5d) was essentially identical to a wild-type CKM class average (the mass of the missing 83 residues being too small to be easily detected in a low-resolution 2D map). We also carried out CTD phosphorylation assays to test the effect of the Srb10-1 mutation on the CTD kinase activity of Cdk8 and found that the mutant's kinase activity is indistinguishable from that of wild type (data not shown). When we examined the interaction of the Srb10-1 CKM mutant with Mediator by EM, we found that binding of the mutant CKM to Mediator was diminished overall and that the fraction of Mediator-CKM particles showing a contact involving the Cdk8-CycC end of the CKM was much lower than for wild-type CKM ( Fig. 5e ; ~10% and ~60%, respectively). Both of these observations are consistent with EM and biochemical data pointing to a contribution from the 83 C-terminal residues of Cdk8 to the formation and stability of the Mediator-CKM complex.
As indicated above, the Srb8-1 Med12 mutation also resulted in introduction of a stop codon that replaced the sequence encoding residue Glu375, which prevented translation of 1,053 (74% of total residues) C-terminal residues of Med12. Not surprisingly, this resulted in disruption of CKM integrity, and only CycC and Cdk8 were recovered when we attempted purification of the mutant CKM from a strain bearing a TAP tag at the CycC C terminus (Fig. 5f) . On the basis of our observations of Mediator-CKM interaction, we would expect diminished interaction of the Srb8-1 mutant CKM with Mediator. Therefore, both the C-terminal truncation of Cdk8 in the Srb10-1 Cdk8 mutant and disruption of CKM complex integrity in the Srb8-1 Med12 mutant would result in diminished interaction of the CKM with Mediator. This suggests a possible common mechanism for compensation of CTD truncations by these SRB mutations: we hypothesize that a shortened CTD would partially hinder interaction of RNAPII with Mediator and that such interaction is facilitated by a reduction of steric hindrance to CTD binding in mutant CKM complexes showing decreased interaction with Mediator.
DISCUSSION
Our EM analysis of the yeast CKM revealed an elongated structure with the Cdk8-CycC kinase-cyclin pair and Med13 flanking a centrally positioned Med12 (Fig. 1g) . There appears to be no direct interaction between Cdk8 and Med12, and Med13 does not seem to contact either Cdk8 or CycC. Yeast and human CKMs appear to be highly homologous, as evidenced by the similarity of their structures (Figs. 1 and 3a) , the close correspondence between the 3D structures of their Cdk8-CycC kinase-cyclin pairs (Fig. 1h) and comparable interaction with Mediator through a strong interaction involving CKM subunit Med13 and a hook-like feature formed by middlemodule subunits at one end of the Mediator structure (Figs. 2c and 3a and Supplementary Fig. 3c,d) .
It has been reported that CKM transcription repression is independent of its Cdk8 kinase activity 18, 19 (also discussed in Our observations suggest that CKM repression is due to an effect on CTD binding to Mediator and on holoenzyme formation (Fig. 6) . We found that the CKM competes with RNAPII for interaction with Mediator (Fig. 5a,b) and that binding of the CKM to Mediator interferes with CTD-dependent RNAPII interaction with Mediator ( Supplementary Fig. 6g ). We show here that although incubation of yeast Mediator and RNAPII results in the formation of some holoenzyme particles, a recombinant CTD or RNAPII is mostly seen binding a site on the middle module that overlaps with the CKM-interaction site (Fig. 4) . In addition, the proportion of holoenzyme particles is increased several fold if Mediator and RNAPII are incubated in the presence of an activator. We also show that Mediator-RNAPII particles isolated directly from yeast show RNAPII binding to Mediator in various positions covering the range from middle-to head-module binding. We believe that CTD-dependent binding of RNAPII to the backside of the middle module probably represents an early step in the holoenzyme formation process that can be blocked by CKM binding (Fig. 6) . The proposition that the CKM interferes with an early step in preinitiation-complex formation is consistent with reports that the CKM has no effect on transcription by an alreadyformed preinitiation complex 6, 18 and is also consistent with our observation that the presence of activator facilitated the formation of a full Mediator-RNAPII holoenzyme. CKM interference with CTD-dependent Mediator-RNAPII interaction explains why components of the yeast CKM were first identified in a screen for mutations that compensate for truncation of the RNAPII CTD. If partial truncation of the CTD decreases CTD binding to Mediator, disruption of CKM's structural integrity or abatement of its interaction with Mediator would facilitate it. Consistent with this argument, two CKM mutations with a compensatory effect for CTD truncation, an Srb10-1 Cdk8 mutation that stops translation of the 83 C-terminal residues of Cdk8 and diminishes Mediator interaction without affecting kinase activity and an Srb8-1 Med12 mutation that stops translation of 1,053 C-terminal residues and results in disruption of CKM integrity, result in decreased interaction of the CKM with Mediator.
We have reported that interaction of RNAPII with the head module results in a polymerase conformation change and a measurable increase in transcription 33 . Interaction of RNAPII with the head module could represent the final stage in the holoenzyme formation process. Modulation of holoenzyme formation, for example through interference by the CKM with CTD-dependent RNAPII interaction with the middle Mediator module or the effect of an activator that would help the transition of RNAPII from the middle to the head modules (presumably through some effect on Mediator conformation), may be critical for the mechanism of Mediator regulation.
EM analysis of yeast Mediator reveals a marked conformational flexibility. Mediator is extremely pliable, and we have not detected long-range correlations between the conformations of different portions of the Mediator structure 5 . This would seem to argue against a model for the Mediator mechanism in which a specific binding event (for example, binding of the CKM or an activator) would result in a single well-defined Mediator conformation that could directly lead to a specific functional outcome (for example, activation of transcription from a specific promoter). Conformational analysis of other macromolecular complexes, such as the ribosome 35 or mammalian fatty acid synthase 36 , indicate that they can access a number of related conformations and that it is only the distribution of particles between these possible conformations that is altered by interaction with a given factor. We believe that the results from our study of the Mediator-CKM interaction illustrate the complexity of Mediator regulation and suggest that competition among different factors for binding to Mediator could be a fundamental aspect of the Mediator regulation mechanism.
METhODS
Methods and any associated references are available in the online version of the paper.
Accession codes. The CKM cryo-EM map (EMD-5588) and the map of the Mediator-CKM complex (EMD-5589) have been deposited in the EM Database.
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